Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 4810-4813, November 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aisenberg, A. C.
Right arrow Articles by Wilkes, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aisenberg, A. C.
Right arrow Articles by Wilkes, B. M.

Relevance of Surface Markers in Chronic Lymphocytic Leukemia to Acute Lymphocytic Leukemia1

Alan C. Aisenberg2 and Barbara M. Wilkes

Oncology Unit of the Department of Medicine and the Huntington Memorial Laboratories, Massachusetts General Hospital, Boston, Massachusetts 02114

The surface membrane of the B-lymphocyte of chronic lymphocytic leukemia (CLL) has been subject to detailed investigation over the past decade. Surface immunoglobulin of low density, punctate in distribution, without the tendency to polar cap formation, and clonal with respect to light and heavy chains, is characteristic. Other B-cell properties include the presence of the la antigen and the receptor for the C3d portion of complement. The CLL surface membrane lacks such T-cell attributes as the ability to form rosettes with sheep erythrocytes and reactivity with anti-T-cell antisera, although T-cells may be increased early in the disorder. CLL is believed to be a proliferation of a B-lymphocyte of the medullary cord of the lymph node, although the exact place of this cell in lymphocyte development remains to be clarified. Surface markers are useful in distinguishing classical B-cell CLL from other proliferations of small lymphocytes (lymphosarcoma cell leukemia of follicle-center B-cells, T-cell CLL, Sézary syndrome, and reactive lymphocytosis).

1 Presented at the Conference on Cell Markers in Acute Leukemia, March 4 and 5, 1980, Bethesda, Md.

2 To whom requests for reprints should be addressed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.